Psychometric properties of the Japanese version of the Weiss Functional Impairment Rating Scale: Self-Report
Tóm tắt
The Weiss Functional Impairment Rating Scale Self-Report has been translated into nine languages and has been widely used in assessing functional impairment of adults with ADHD. This study is a psychometric validation of the WFIRS-S in Japanese. The WFIRS-S-J and other questionnaires were administered to 46 adults with attention-deficit–hyperactivity disorder (ADHD), 104 control adults, and 889 university students. ADHD diagnoses were made using the Japanese semi-structured diagnostic interview for adult ADHD, which is compatible with the DSM-5. All subscales of the WFIRS-S-J had Cronbach’s α values of around 0.80. Total scores on the WFIRS-S-J had high test–retest reliability after a 2-week interval. The total score, subscale scores, and 59 of the individual item scores of the 70 items in the WFIRS-S-J were significantly higher in the ADHD group than in the other two groups, although more than half of the items in subdomain G (risk) showed floor effects and did not reach significance. Generally WFIRS-S-J subdomain scores were moderately correlated with scores on the Japanese version of Conners’ Adult ADHD Rating Scales Self-Report subscales. WFIRS-S-J scores were also correlated (albeit more weakly; 0.31 ≤ r ≤ 0.55) with Beck Depression Inventory II total scores. The WFIRS-S-J showed acceptable psychometric properties, although further study is necessary.
Tài liệu tham khảo
Able SL, Johnston JA, Adler LA, Swindle RW (2007) Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med 37:97–107
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV TR). American Psychiatric Association, Washington, DC
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Arlington
Baird J, Stevenson JC, Williams DC (2000) The evolution of ADHD: a disorder of communication? Q Rev Biol 75:17–35
Barkley R (2011) Barkley Functional Impairment Scale. Guilford, New York
Biederman J, Mick E, Faraone SV (2000) Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 157:816–818
Brod M, Perwien A, Adler L, Spencer T, Johnston J (2005) Conceptualization and assessment of quality of life for adults with attention-deficit/hyperactivity disorder. Prim Psychiatry 12:58–64
Brod M, Johnston J, Able S, Swindle R (2006) Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res 15:117–129
Canadian ADHD Resource Alliance (CADDRA) Canadian ADHD practice guidelines. http://www.caddra.ca/. Accessed 11 June 2016
Cheung KK, Wong IC, Ip P, Chan PK, Lin CH, Wong LY, Chan EW (2015) Experiences of adolescents and young adults with ADHD in Hong Kong: treatment services and clinical management. BMC Psychiatry. doi:10.1186/s12888-015-0478-x
Conners CK, Erhardt D, Sparrow E (1999) Conners’ adult ADHD rating scales (CAARS) technical manual, North Tonawanda. Multi-Health Systems, Inc., New York [Nakamura K., Someki S., Onishi M. (Trans) (2012) CAARS Japanese Version. Kanekoshobo, Tokyo (in Japanese)]
De Bruyckere K, Bushe C, Bartel C, Berggren L, Kan CC, Dittmann RW (2016) Relationships between functional outcomes and symptomatic improvement in atomoxetine-treated adult patients with attention-deficit/hyperactivity disorder: post hoc analysis of an integrated database. CNS Drugs 30:541–558
Gajria K, Kosinski M, Sikirica V, Huss M, Livote E, Reilly K, Dittmann RW, Erder MH (2015) Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder. Health Qual Life Outcomes. doi:10.1186/s12955-015-0379-1
Hirayama H, Hirayama KK (1987) The sexuality of Japanese Americans. In: Lister HL (ed) Human sexuality, ethnocultural, and social work. Routledge, London, p 95
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Zaslavsky AM (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716–723
Kojima M, Furukawa TA, Takahashi H, Kawai M, Nagaya T, Tokudome S (2002) Cross-cultural validation of the Beck Depression Inventory-II in Japan. Psychiatry Res 110:291–299
Komiya N (1999) A cultural study of the low crime rate in Japan. Br J Criminol 39:369–390
Kurita H, Koyama T, Osada H (2005) Autism-Spectrum Quotient-Japanese version and its short forms for screening normally intelligent persons with pervasive developmental disorders. Psychiatry Clin Neurosci 59:490–496
Landgraf JM (2007) Monitoring quality of life in adults with ADHD: reliability and validity of a new measure. J Atten Disord 11:351–362
Mannuzza S, Klein RG, Addalli KA (1991) Young adult mental status of hyperactive boys and their brothers: a prospective follow-up study. J Am Acad Child Adolesc Psychiatry 30:743–751
Mimura C, Griffiths P (2007) A Japanese version of the Rosenberg Self-Esteem Scale: translation and equivalence assessment. J Psychosom Res 62:589–594
Nagy P, Häge A, Coghill DR, Caballero B, Adeyi B, Anderson CS, Sikirica V, Cardo E (2016) Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate. Eur Child Adolesc Psychiatry 25:141–149
NIMH (1985) CGI: clinical Global Impression Scale—NIMH. Psychopharmacol Bull 21:839–844
Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, Morris KA, Santosh P, Sonuga-Barke E, Taylor E, Weiss M, Young S, British Association for Psychopharmacology (2007) Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 21:10–41
Otsubo T, Tanaka K, Koda R, Shinoda J, Sano N, Tanaka S, Aoyama H, Mimura M, Kamijima K (2005) Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview. Psychiatry Clin Neurosci 59:517–526
Rasmussen P, Gillberg C (2000) Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry 39:1424–1431
Sheehan DV (1983) The anxiety disease. Charles Scribner and Sons, New York
Takeda T, Tsuji Y, Uwatoko T, Kurita H (2015) Reliability and validity of ADHD diagnostic criteria in the Assessment System for Individuals with ADHD (ASIA): a Japanese semi-structured diagnostic interview. BMC Psychiatry. doi:10.1186/s12888-015-0525-7
Tarakçıoğlu MC, Memik NÇ, Olgun NN, Aydemir Ö, Weiss MD (2015) Turkish validity and reliability study of the Weiss Functional Impairment Rating Scale-Parent Report. Atten Defic Hyperact Disord 7:129–139
Weiss MD, Craig SG (2016) Validation of the Weiss Functional Impairment Rating Scale Self Report (WFIRS-S) in a clinical population of ADHD youth age 14 to 18. American Professional Society for ADHD and Related Disorders. 16 January 2016, Washington DC
Weiss MD, Murray C (2003) Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ 168:715–722
Weiss MD, Safren SA, Solanto MV, Hechtman L, Rostain AL, Ramsay JR, Murray C (2008) Research forum on psychological treatment of adults with ADHD. J Atten Disord 11:642–651
Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P (2005) ISPOR Task Force for Translation and Cultural Adaptation. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 8:94–104
Yoshida T, Otsubo T, Tsuchida H, Wada Y, Kamijima K, Fukui K (2004) Reliability and validity of the Sheehan Disability Scale-Japanese version. Jpn J Psychopharmacol 7:1645–1653